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Abstract 
On this document we will present the interview done to Montserrat Jané, patent technician of the Patents 
Centre of the University of Barcelona. This interview was done on May 2007 by Victor Cavaller for 
SCIWATCH scientific magazine. In this interview, Montserrat Jané talks about the work that is being 
held at the centre, about the people that work there and their professional profiles, about the centre’s 
structure, its relations with other agencies, organisms and entities from the private and public sector, and 
also about the information fluxes and the different procedures that are being done and held in the patent 
field. 
 
                                                 
1
 Interview done on Wednesday the 9th May of 2007, in the offices of the Patents Center of the University of 
Barcelona. Interview has been done by Victor Cavaller. Transcription has been done by Matias Welling. 
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The Patents Center is a research facility of the University of Barcelona that, 
since year 1987, dedicates itself mainly to tasks of research, divulging and 
teaching in the field of the patent rights and documentation. The center counts 
on specialized staff to carry out research on patentability of inventions, and with 
several Patent Rights Agents, registered as such, that are responsible for the 
writing and the whole procedure of requesting a patent. 
 
How is the team of work that you dedicate to each of the tasks composed? 
How do you organize the working teams? Which are the main sequences of 
activity at the Patents Center? 
 
The team at the Patents Center is formed by: 
. Pasqual Segura 
. Bernabé Zea 
. Lidia Cases 
. Montserrat Jané 
. Nuria Sants 
 
Which are the professional main profiles of the patents technicians? 
 
The main professional profiles at the Center have technical and scientifical background with 
specialization in the technical or scientific area in which the patentability is being studied. We value not 
only knowledge on patents but also the knowledge about documentation. In particular, the center of 
patents of the UB is especially focused towards the areas of chemistry, biology, biochemistry or 
biotechnology, even though these areas are not at all restrictive. 
 
Which sectors from the industry are the main customers of the services that you offer, and how do 
you manage their patents? 
 
Besides the individuals who work in general areas, the main companies that come to the Patents Center 
are from the area of pharmacy, chemistry, biology, biochemistry or biotechnology. From the creation of 
the center, about 30 projects have been formalized with success. This number is explained because of the 
fact that in the UB the Spanish patent is usually requested, and this type of patent offers a year of 
protection and therefore, an international patent is requested, PCT, which as a matter of fact will never be 
granted but allows the requester to win time of protection; up until two years and half. All this extra time 
allows us to visualize if this project can effectively be transferred to the business world. If after this 
period this technological transfer has not been made, the project is abandoned. On the other hand, if the 
project is viable, we proceed to patenting the invention in other countries. The interest of the university is 
precisely achieving a successful transfer to the business world, and this will only be possible if this 
invention has commercial possibilities. To go for the international patenting is very expensive, therefore 
the university will only do it if, from its point of view, is plausible. In accordance with the current 
regulations (posterior annex) and once the technological transfer has been made, the University will have 
the right to an economic compensation corresponding to a proportion of the derivative benefits of the 
economic exploitation of the invention. It is contemplated that the researchers as well as the university 
have the right to receive economic compensations, in equal parts. 
 
The Center of Patents is one of the agents in the System of Innovation of the UB Group, in which we can 
also find: 
 
•  Agency of Valuation and Commercialization of the Results of the Research (AVCRI) 
• Center of Innovation of the Bosch i Gimpera Foundation  
• Scientific Park of Barcelona 
• Scientifical and technical services 
Figure 1.: Montserrat 
Jané 
Jané, M. / SciWatch Journal 1 (2008), Issue 1, 4 - 13 
6 
 
• Clinic Foundation 
• August Pi i Sunyer biomedical research institute (IDIBAPS) 
• Bellvitge biomedical research institute (IDIBELL) 
 
How do the services of the Patents Center of the UB organize with 
the other agents of the System of innovation of the UB group? 
 
The patents center of the UB as well as the Center of innovation of the 
Bosch i Gimpera Foundation are independent units of the AVCRI, even 
though they work in collaboration in certain projects. This means that 
only the tasks that the Patents Center does regarding patents are being 
conducted in collaboration with the AVCRI and the Center of innovation 
of the Bosch i Gimpera Foundation. In this collaboration, the mission of 
the Patents Center is based on protecting, through patents, the inventions 
of the UB environment. This implies that the initial search, the 
patentability analysis, the writing of the request of patent and the 
posterior procedure are all conducted in collaboration. 
 
The internal process of protection of inventions in the University of Barcelona starts with the researchers 
filling the form, which will then be sent to the AVCRI for the initial valuation. From here on, a first 
committee is formalized by members of the three areas (AVCRI, Patents Center, and Center of innovation 
of the Bosch i Gimpera Foundation) that evaluates the project. 
The committee then proceeds to the writing of a report that analyzes different aspects such as: The Patents 
Center studies the patentability, the Bosch i Gimpera Foundation studies commercial aspects and possible 
feasibility of the technological transfer. Then this report is remitted to a management committee that will 
decide if a working team is going to be formed or not, in other words, if the project is going to be carried 
out or not. 
 
Besides from patent consultancy, the Patents Center of the UB develops other functions such as: 
- Teaching 
- Free and public information service for general advice in subjects such as patentability (in 
collaboration with the CIDEM; Center of Innovation and Entrepreneurial Development) oriented 
to individuals as well as companies and entities that want to brief themselves about the procedure 
which is necessary to protect an invention with a patent. The companies or individuals concerned 
can then be remitted towards agents of the patent rights, which offer a commercial service for 
patenting inventions, or we can give them advice so that they patent the invention by themselves. 
In this second case, individuals must start the work of searching in the data bases to verify that 
the invention is effectively new and exclusive. They can carry out this search in commercial or 
free databases (there are commercial data bases with effective search tools based on indexing and 
standardization of contents by different criteria of search. There are also free open databases that 
unfortunately are not as effective or complete as their commercial counterparts). In this context, it 
is recommended to begin using the open access data bases, and then, if they are not successful, 
continue the search with professional data bases. 
- Service of library specialized in intellectual and patent rights. 
 
The institutions mentioned above, Agency of Valuation and Commercialization of the Results of the 
Research (AVCRI), Center of Innovation of the Bosch i Gimpera Foundation, Scientific Park of 
Barcelona, Scientifical and technical services, Clinic Foundation, August Pi i Sunyer biomedical research 
institute (IDIBAPS), and Bellvitge biomedical research institute (IDIBELL) can be considered like 
customers of the Patents Center, because they are users of the services that the Patents Center offers. 
Figure 2.: Patents centre at 
Barcelona’s Parc científic  
Figure 2.: Patents Center 
headquarters in Barcelona 
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On the other hand, the center also offers the UB Group and the Scientific Park of Barcelona a series of 
services addressed to the public in general and, especially, to the linked entities: The center is one of the 
agents of the System of Innovation of the UB Group, in which it is in charge of the protection of the 
results of the research with patents, in accordance with the Regulations about Intellectual and Patent 
Rights, in collaboration with the agency of Valuation and Commercialization of the Results of the 
Research (AVCRI). 
 
Which is the policy related to the management of the patent and intellectual rights of the UB? To 
what extend does this policy engage the activities of the Patents Center? 
 
The AVCRI is the entrance door for the projects that will pass through the process that implicates the 
patents center as well as the Bosch i Gimpera Foundation. We, the Patents Center, are not an integral part 
of the AVCRI, even though we participate in narrow collaboration with the rest of institutions involved in 
the process. Our management policy of the patent and intellectual rights is in coherence with the patents 
policy of the UB, based on the selection with clear-cut criteria, of those projects that can have financial 
feasibility. In this way only those projects with real potential will be thrown ahead. 
 
The center has a public access documental database and offers a free information service about subjects 
related with the patent rights and an on-demand research service for carring out searches in patent 
databases. 
 
Which are the main users of the information services offered by the Patents Center? Which are the 
main sources of information of this service? 
 
In the library, we offer individuals the opportunity to consult books on the subject, and this service is 
mainly addressed to lawyers and technicians specialized in the area. The patent documents are already 
available online, on different open as well as professional data bases, therefore the main disposable 
resource of the library are updated publications and theory books on the subject of patents, patent rights 
and copyright. Supply of patent documents is also offered, even though this service is not being requested 
as much, given the mentioned fact before, that the documents of patents are already present in data bases 
on the Internet. 
 
The center also takes care of the Spanish representation of Chemical Abstracts Service (CAS) and STN 
International. 
 
Which are the concrete terms of the collaboration between CAS, STN international and de Patents 
Center? 
 
There is an agreement between the American Chemical Society (CAS, Chemical Abstracts Service) and 
the UB for which the staff of the patents center makes the tasks of CAS representation in Spain. This 
agreement represents a benefit for the University of Barcelona for the prestige of exercising this function, 
as well as for the remuneration agreed for making this representation. Besides representation and 
promotion, the Patents Center of the UB gives support to the users who want to know the functioning of 
these data bases in depth. A service of advice and orientation for the customers of CAS is also offered. 
 
Apart from the STN International software, which other software of exploration/analysis of the 
production of patents do you use? 
 
In the patents center, STN is used as a retrieval tool for documents of patents as well as for scientific 
articles, to cover all the recovery needs of the center. SNT offers more that 225 data bases of different 
specific technical fields. 
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Which do you think are the main trends that can be observed when companies write their patent 
documents, both respecting the current law but at the same time trying to protect their inventions? 
 
Patent laws establishes which innovations can be protected with patents and stipulates that only the 
following concepts can be protected: In first place products per se, and that is the maximum possible 
protection since it protects the product itself and nobody can sell it during the time of protection, 
independently of the procedure that he uses to arrive at it; in second place the procedures to arrive at a 
final product are also subject to eventual protection, in third place indications and therapeutical uses of a 
determinate product can also be protected. 
The law on patents of 1986 did not allow the protection of products per se, even though the European 
Office of Patents was against the philosophy of this public Spanish law. This situation changed with the 
new 1992 law that adapted the Spanish regulation to the usual regulations in Europe and WTO member 
countries. This normative shift has provoked that many companies with patents transacted and published 
before year 1992, invoked later on the TRIPS 1994 international agreement (WTO agreement that 
establishes among other things, that it is possible to change the protection of an invention to the best 
possible protection available) to make the patents former to 1992 transform into product protection per se, 
therefore adopting the best protection available in Spain. There have been several sentences of Spanish 
courts that effectively affirm that patent protection prior to 1992 can in fact become product protection, in 
coherence with the TRIPS agreement. 
When patenting, the regulations require that the description on the patent document is written in a 
sufficient way that allows reproduction: the so-called criteria of sufficiency. The companies usually 
comply with the criteria of sufficiency, even though there are ways of partially protecting the know-how 
of an invention while complying with the law. A good example could be the case of companies of the 
chemical sector that want to patent a chemical reaction that produces a determinate product. The patent 
can be written explaining the way to make it correctly, but without clarifying that there is an exact point 
of temperature in with this chemical reaction is much more efficient. The chemical process can be carried 
out at other temperatures, and this is explained in the patent, but the exact temperature in which that retain 
is highly efficient is not revealed and by doing this, the companies partially protect their know-how. It is 
more or less usual for companies to obviate certain aspects of the know-how in order to protect the 
differential competitive advantage of the company. In the US though, this is not possible. In America the 
regulations about copyright and industrial property are different and the criteria of sufficiency also 
includes the requirement of  explaining, in the patent written document, the best known way for the 
applicant to arrive to the final product, the best mood. 
 
Another aspect related with the written up of patents is the fact that an inventor who has an invention with 
eventual commercial feasibility, must protect his invention (and specially the know-how) before starting 
to look for finance support to develop that invention. By doing this, and with the patent in hand, the 
inventor is in a better position to negotiate the development of that innovation since he can explain his 
patent, as far as where it is necessary, and keep the know-how for a later moment once he has a good 
agreement. 
 
In this context, the so-called nebulous of patents is a very common business strategy for protecting 
innovation while patenting and complying with the regulation. In order to do that, companies trying to 
protect one specific innovation do not only create the patent for that specific invention, but also create a 
variable number of other patents closely related, all in order to create confusion for the competitors, 
distorting the first intention of the company. By these techniques of lack of information companies can 
confuse competitors when they carry-out their technological watch functions. 
 
Courses and conferences 
 
The center organizes courses and conferences about the system of patents, seminars on documentation in 
scientific and technical data bases and forums of discussion. 
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Which is the balance of the latest years of the formation courses? 
 
• At first, annual conferences were made consecutively once in Barcelona and later in Madrid, 
nowadays annual conferences are being held in both cities simultaneously, therefore we can say 
that these conferences have been consolidated. 
• This year we are holding the European Qualifying Examination courses addressed to individuals 
wanting to become European patent agents. 
• We are also holding free regular conferences on the subject, the "Jornadas de Estudio y 
Actualización Materia de Patentes" that are very popular among experts in the subject. 
• Several educational activities are developed in university centers in collaboration with the OEPM 
(the Spanish patent office). We organize 10 sessions per year, structured like 4 hour conferences 
where the patent and intellectual rights are explained, as well as explaining the services that the 
Patents Center and the OEPM can offer. 
• Courses and masters in prestigious institutions like the University of Alicante, ESADE, IQS, 
University of Navarra, Polytechnic University of Catalonia etc. that are imparted by the members 
of the center of patents. 
• The information of the courses and conferences that the Patents Center organizes and/or 
participates in, are available on the center’s website: 
http://www.pcb.ub.es/centredepatents/cursos.htm 






































What are the main customers of this service?  
 
The main users of the courses are in the pharmaceutical industry, of great weight in Catalonia, and other 
industrial and scientific Catalan strategic sectors, as perhaps the chemical sector. The fact that these 
sectors are precisely those who give more importance to activities related to patents can be explained by 
the fact that in these sectors the investments necessary to do research and develop products are quite 
important, and only a tiny portion of the projects that start will have commercial viable applications. 
Patents and in general the legal framework of these are vital in areas with R & D intense activity, such as 
chemical or pharmaceutical. If companies in these sectors cannot obtain protection for their inventions 
against the competition, they cannot justify or recoup the huge financial outlay required to do that 
research to develop new products.  
 
Do you consider the possibility of forming professionals dedicated to the foresight and technology 
watch? 
 
At the patents center we started working on projects that come through AVCRI and are presented by 
researchers. We can advise them on issues mainly related to patentability, procedure for patenting, and 
the economic viability of the projects. The guidance given on the way a specific investigation should go 
are rather limited. Throughout the process that is undertaken to patent an invention, the members of the 
Figure 3.: academic activities carried out at the Patent Center in the UB 
Among the academic activities that the Patent Center regularly organizes, it is offered: 
 
• Days of study and update on patents ("The Patent Monday"): This is a discussion forum that brings 
together more than three hundred patent experts. During the academic year about five sessions are 
announced through a distribution list. If you want to enter, contact Pascual Segura.  
 
• Workshop to prepare for the European Qualifying Examination (EQE) of the European Patent Office: 
The objective of this course is to train Spanish candidates who want to improve their professional 
practice and submit to the European Qualifying Examination ( EQE) in order to become agents of 
European Patents (you'll find more information about the EQE on the site of the EPO).  
 
• Course on patents and utility models: patentability, drafting, infringement, litigation, transfer and 
documentation: Modular course (two weeks), in alternate editions in Barcelona and Madrid, aimed at 
professionals (managers, technicians, documentary makers, consultants, lawyers, jurists, etc.). and 
inventors who have to deal with patents and technology transfer, and is also particularly designed for 
people interested in substantive issues of infringement and invalidity. 
 
• Documentation seminars on databases and scientific and technical patents: These seminars are aimed at 
people interested in learning how to do searches in commercial databases, which provide access to 
information not available from other sources that can be found on Internet. 
 
• Training Programs for companies and public research: Courses are offered on demand, both for 
companies (R & D departments), universities and public research. Many of these activities are done in 
collaboration with other agencies such as:  
 
- The Spanish Patent and Trademark Office (OEPM),  
- The Information and Business Development Center (CIDEM) of the Generalitat de Catalunya  
- The European Patent Office (EPO)  
- The University of Strasbourg’s Centre d'Études Internationales de la Propriété Industrielle 
(CEIPI) 
- The CAS of the American Chemical Society 
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multidisciplinary team (from AVCRI, the patents center, and the Bosch I Gimpera foundation) who 
analyze the cases, can provide general guidance, but cannot give specific guidelines on what should be 
included in a project. The training of professionals in the field of technology monitoring and foresight, 
understood as feedback, is not a priority right now.  
 
Where is the Patents Center located inside the triangular structure University - Institutions - 
Companies? 
 
In this triangular structure, the Patent Center cannot be seen as a “University – Business” relation, 
because there is no close collaboration between the Center and private companies. The Center is not an 
“Institutions – University” agent either, except for the fact that it receives public funding and that it works 
with the AVCRI, which is a public – private entity, In any case, the daily work of the Patents Center 
cannot be considered as work carried on in the public administration. So in the end, we can say that the 
center is located inside the University pole, because its goal is to protect the inventions created in the UB, 
and the institutions surrounding the UB, exclusively. This is also true, because the relationship with the 
companies merely intends to transfer, i.e. "sell" the inventions and technology from UB to private 
companies so that they develop projects to arrive at the product that will reach the market. The key in this 
triangle is that all the research being done in universities cannot only end up in the scientific literature, but 
it must be patented and eventually arrive to the society as commercial products. In consonance with these 
goals, the public sector is financing and promoting the patenting of inventions and the technological 
transfer from universities to the private sector. 
 
Since 1988 the Patents Center has been involved in promoting the patent system among researchers from 
the UB Group, in order to encourage patent protection of research results and the process of patenting in 
general, under the old 1995 UB Regulation on Patents.  
 
Which measures are you developing with the scientific community in the UB in consonance with 
these goals?  
 
The Patent Center became involved in teaching and promotion in the field of patents as a mean to 
promote and encourage the protection of inventions in general and disseminate knowledge on the subject. 
In some sense the greatest contribution of the Patents Center is to disseminate the culture of patenting and 
publishing not only in universities. Until recently, this lack of will and lack of patenting culture made 
many innovations with good commercial potential never come to receive the thrust of companies for the 
commercial development of a product. Fortunately, we think that this way of thinking is gradually 
changing here in Spain. 
 
To have all the information regarding the transfer of knowledge and technology of the UB Group, 
interested researchers and companies can visit the Transfer Gateway of UB Group and the AVCRI. 
 
Do you consider the technology transfer of the results of the scientific research of the UB to 
be positive / adequate? What are the main current deficits?  
 
From the Patents Center we believe that many inventions have been successfully transferred to 
the world of business, although sometimes the projects end up “dying” because they have no 
commercial applicability or the right timing. In this context we believe that much progress has 
been made, especially with the creation of AVCRI. This agency represented a great improvement 
for the rationalization of resources and for the pushing forward of projects in a reasonable way, 
which is, patenting only what may really have practical potential and not just patenting 
everything that is being investigated, as it was done years ago at the university level. 
 
The main problem in the field of patents is that traditionally researchers have begun to publish in 
scientific journals before attempting to patent, in violation of the patent regulation defined by the new 
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laws governing intellectual property. With the new laws, researchers have to be very careful with what 
they say in congresses, and what they publish in their doctoral dissertations, or articles. It is important to 
patent before disclosing an innovation. Again, initiatives such as the Patents Center, the AVCRI or the 
intervention of the BiG Foundation are of great importance. 
Technologies to transfer: 
Requested Title of the patent  More information  
09/10/2003  Aparato eléctrico para la estimulación simultánea, controlable y duradera de células cultivadas en placas multipozo. 
Oferta tecnológica 
en el Innovation Relay 
Centre (IRC)  
08/03/2004  Péptidos como portadores penetrantes de células  -  
18/06/2004  Nuevo agente terapéutico para el tratamiento de la infertilidad y/o 
subfertilidad masculina en mamíferos -  
23/06/2004  Compuestos para el tratamiento de la inflamación del sistema nervioso 
central 
Oferta tecnológica 
en el Innovation Relay 
Centre (IRC) 
23/06/2004  Compuestos para el tratamiento del daño agudo del sistema nervioso 
central 
Oferta tecnológica 
en el Innovation Relay 
Centre (IRC) 
29/06/2004  Nuevo uso terapéutico del formoterol 
Oferta tecnológica 
en el Innovation Relay 
Centre (IRC) 
26/11/2004  Método de identificación de pigmentos de una sola célula mediante 
espectrofotometría de imagen confocal en comunidades fototróficas -  
25/02/2005  Sensor radio-químico para fluidos  
Oferta tecnológica 
en el Innovation Relay 
Centre (IRC) 
13/04/2005  Extracto de un alga laminaria como agente terapéutico -  
29/07/2005  Composiciones farmacéuticas para el tratamiento de la enfermedad de Alzheimer y otros tauopatías -  
08/09/2005  Nuevo agente quimioterapéutico para el tratamiento del cáncer  Oferta tecnológica  
08/09/2005  Compuestos para el tratamiento del Síndrome de Inmunodeficiencia Adquirida Oferta tecnológica  
14/10/2005  Compuestos para el tratamiento de la fibrilació auricular -  
14/10/2005  Compuestos para el tratamiento de la enfermedad de Parkinson -  
27/10/2005  Intermedio y procedimiento para la preparación de levetiracetam Oferta tecnológica  
20/04/2006  Compuestos inhibidores de acetilcolinesterasa para el tratamiento de la 
enfermedad de Alzheimer -  
 
 
Table 1: Technologies to be transferred 




Year  Buyer  Patent  Technical sector  Contract 
2006  Unidad Biotecnológica Analítica (UBAN)  WO 2005045425  Analytic Instrumentation license  
2006  ADASA Sistemas  pendiente  Analytic Instrumentation license 
2005  Cancer Research Technology Limited  WO 2004031130  Cancer treatment products license 
2004  Advanced in Vitro Cell Technologies  WO 2004003566  Diagnosis license 
2004  Genmedica Therapeutics  WO 0238152  Diabetes treatment and prevention products license 
2004  Biocontrol Technologies  WO 03000866  Microbiology  license 
2004  Pharma Mar  WO 0212240  Cancer treatment products sold  
2004  Seiko Epson Corporation  WO 03079624  Electronics  sold 
2004  Advanced in Vitro Cell Technologies  
ES 2.192.495 i WO 
03080076  Lymphoma treatment products sold 
2002  E-Sense Systems  ES 2.173.048 i WO 02077631  Analytic Instrumentation sold 
2002  Oleoyl-estrone Developments  ES 2.173.049  
Diabetes treatment and prevention 
products sold 
2001  Química Farmacéutica Bayer  ES 2.187.276  Obesity treatment and prevention products sold 
2001  Balagué Center  WO 0052477  Drug selection kit sold 
1997-
2002  Glen Research Corporation  US 6.153.742  Cyclic oligonucleotides license  
1996  Química Farmacéutica Bayer  ES 2.108.642 US 5.595.763  
Pharmaceutical composition for 




For more information on these technologies contact with the Center for Innovation, Bosch i 
Gimpera Foundation. You can find more technology offers from other universities and research 
centers through the search engine “European service for Transfer of Technology”. This includes 
the Technology surveillance service (AMT), useful for updates on the latest offers and demands 
in the area of interest. 
Table 2. : Transferred technologies 
